Galleon Pharmaceuticals
company
About
Galleon Pharmaceuticals is engaged in the discovery and development of medicines for breathing-control conditions in the United States.
- 11 - 50
Highlights
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $10M
- Industries
- Biotechnology,Life Science,Pharmaceutical
- Founded date
- Jan 1, 2003
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Galleon Pharmaceuticals engages in the discovery and development of medicines for breathing-control conditions in the United States. It focuses on developing a portfolio of therapeutics for the treatment of sleep apnea, ventilator weaning, anesthetic/analgesic-induced respiratory depression, COPD, obesity-hypoventilation syndrome, and other common diseases. The company was incorporated in 2003 and is based in Horsham, Pennsylvania.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$10M
Galleon Pharmaceuticals has raised a total of
$10M
in funding over 2 rounds. Their latest funding was raised on
Jun 11, 2015 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 11, 2015 | Series B | $10M | 1 | — | — | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
